Fibrinogen-to-Albumin Ratio in Familial Mediterranean Fever: Association with Subclinical Inflammation

Abstract

Background Familial Mediterranean fever (FMF) is the most seen monogenic periodic fever syndrome characterised by bouts of fever and serositis. It is known that subclinical inflammation (SI) can persist in the symptom-free period and lead to amyloidosis even under colchicine treatment. This study aimed to evaluate the role of the fibrinogen-to-albumin ratio (FAR) in FMF and its correlation with SI.

Material and Methods A total of 112 patients with FMF and 78 controls were enrolled in this retrospective study. Demographic, laboratory and genetic data were obtained from the hospital records.

Results The FAR values of the FMF cases were significantly higher than the control group (p<0.001). In the FMF group, the patients with SI had higher FAR values than those without SI (p<0.001). FAR was positively correlated with SI (r=0.413, p<0.001). The receiver operating characteristic curve analysis showed that FAR had a higher area under the curve value than albumin and fibrinogen.

Conclusion Detecting SI in patients with FMF is crucial in preventing amyloidosis, the most devastating complication of FMF. FAR is a simple, inexpensive, easily obtained indicator which can be used for reflecting SI in FMF.

Zusammenfassung

Hintergrund Familiäres Mittelmeerfieber (FMF) ist das am häufigsten auftretende monogene periodische Fiebersyndrom, das durch Fieberschübe und Serositis gekennzeichnet wird. Die subklinische Entzündung (SI) kann bekanntlich auch in der symptomfreien Phase fortbestehen und zu Amyloidose führen, selbst unter Behandlung mit Colchicin. Ziel dieser Studie ist es, die Beziehung zwischen Fibrinogen und Albumin (AFR) bei FMF und deren Korrelation mit SI zu untersuchen.

Material und Methoden Insgesamt wurden für diese retrospektive Studie 112 Patienten mit FMF und 78 Kontrollpatienten eingeschlossen. Die demographischen, labortechnischen und genetischen Daten wurden aus den Krankenhausunterlagen entnommen.

Ergebnisse Die Werte von AFR bei Patienten mit FMF waren signifikant höher als die der Kontrollgruppe (<0,001). Patienten mit FMF mit SI zeigten höhere AFR-Werte als FMF-Patienten ohne SI (<0,001). AFR korrelierte positiv mit SI (r=0,413, p<0,001). Die Analyse der ROC-Kurve (Receiver Operating Characteristic) zeigte, dass AFR einen höheren Wert der Fläche unter der Kurve (AUC) hatte als Albumin und Fibrinogen.

Diskussion Die Erkennung von SI bei FMF-Patienten ist entscheidend für die Vermeidung von Amyloidose, der schlimmsten Komplikation von FMF. AFR ist ein einfacher, kostengünstiger, leicht durchzuführender Indikator, der in FMF zur Spiegelung von SI verwendet werden kann.

Key words

albumin - children - familial Mediterranean fever - fibrinogen - subclinical inflammation

Publication History

Received: 12 May 2021
Received: 17 July 2021

Accepted: 24 August 2021

Article published online:
20 September 2021

• References

• 1 Ahsen A, Ulu MS, Yuksel S. et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 2013; 36: 1357-1362
• 2 Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol 2003; 18: 853-859
• 3 Basaran O, Uncu N, Celikel BA. et al. Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients. J Res Med Sci. 2017; 22: 35
• 4 Baykal Y, Saglam K, Yilmaz MI. et al. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 2003; 22: 99-101
• 5 Bayram MT, Çankaya T, Bora E. et al. Risk factors for subclinical inflammation in children with Familial Mediterranean fever. Rheumatol Int 2015; 35: 1393-1398
• 6 Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659-664
• 7 Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2011; 7: 105-112
• 8 Cakmak E, Ece A, Kelekçi S. et al. Comparison of acute phase response during attack and attack-free period in children with Familial Mediterranean Fever. J Clin Exp Invest 2013; 4: 213-218
• 9 Chen C, Liu Y, Han P. et al. Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer. Cancer Manag Res. 2021; 13: 1791-1801
• 10 Gang N, Drenth JP, Langevitz P. et al. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 1999; 26: 890-897
• 11 He Y, Tang J, Wu B. et al. Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis. Clin Chim Acta. 2020; 500: 149-154
• 12 Heilig R, Broz P. Function and mechanism of the pyrin inflammasome. Eur J Immunol. 2018; 48: 230-238
• 13 Holzinger D, Foell D, Kessel C. The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases. Mol Cell Pediatr. 2018; 5: 7
• 14 Kallinich T, Blank N, Braun T. et al. Evidenzbasierte Therapieempfehlungen für das familiäre Mittelmeerfieber : Eine gemeinsame Stellungnahme der Gesellschaft für Kinder- und Jugendrheumatologie und der Deutschen Gesellschaft für Rheumatologie [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology]. Z Rheumatol. 2019; 78: 91-101
• 15 Kelesoglu FM, Aygun E, Okumus NK. et al. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. Clin Rheumatol. 2016; 35: 2757-2763
• 16 Korkmaz C, Ozdogan H, Kasapçopur O. et al. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61: 79-81
• 17 Lachmann HJ, Sengül B, Yavuzşen TU. et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-750
• 18 Li M, Tang C, Luo E. et al. Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome. Biomed Res Int 2020; 2020: 1860268
• 19 Lieber M, Kallinich T, Lohse P. et al. Increased serum concentrations of neutrophil-derived protein S100A12 in heterozygous carriers of MEFV mutations. Clin Exp Rheumatol 2015; 33: S113-S116
• 20 Liu M, Huang Y, Huang Z. et al. The role of fibrinogen to albumin ratio in ankylosing spondylitis: Correlation with disease activity. Clin Chim Acta. 2020; 505: 136-140
• 21 Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 2019; 133: 511-520
• 22 Marino A, Tirelli F, Giani T. et al. Periodic fever syndromes and the autoinflammatory diseases (AIDs). J Transl Autoimmun. 201917; 3: 100031
• 23 Marzouk H, Mostafa N, Khalifa I. et al. Red Cell Distribution Width (RDW) as a marker of Subclinical Inflammation in Children with Familial Mediterranean Fever. Curr Rheumatol Rev 2020; 10: 2174
• 24 Mukhin NA, Kozlovskaya LV, Bogdanova MV. et al. Predictors of AA amyloidosis in familial Mediterranean fever. Rheumatol Int. 2015; 35: 1257-1261
• 25 Ozdogan H, Ugurlu S. Familial Mediterranean Fever. Presse Med. 2019; 48: e61-e76
• 26 Ozen S, Demirkaya E, Erer B. et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016; 75: 644-651
• 27 Özer S, Yılmaz R, Sönmezgöz E. et al. Simple markers for subclinical inflammation in patients with Familial Mediterranean Fever. Med Sci Monit 2015; 21: 298-303
• 28 Pras E, Livneh A, Balow JE. et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998; 75: 216-219
• 29 Skendros P, Papagoras C, Mitroulis I. et al. Autoinflammation: Lessons from the study of familial Mediterranean fever. J Autoimmun. 2019; 104: 102305
• 30 Sohar E, Gafni J, Pras M. et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967; 43: 227-253
• 31 Uluca Ü, Demir F, Ece A. et al. Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever. Ital J Pediatr. 2015; 41: 15
• 32 Watanabe H, Imafuku T, Otagiri M. et al. Clinical Implications Associated with the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related Diseases. J Pharm Sci 2017; 106: 2195-2203
• 33 Xu Q, Yan Y, Gu S. et al. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma. J Immunol Res. 2018; 2018: 4925498
• 34 Varan O, Kucuk H, Babaoglu H. et al. Chronic inflammation in adult familial Mediterranean fever patients: underlying causes and association with amyloidosis. Scand J Rheumatol 2019; 48: 315-319
• 35 Yorulmaz A, Akbulut H, Taş SA. et al. Evaluation of hematological parameters in children with FMF. Clin Rheumatol 2019; 38: 701-707